Therapies And Nanotherapies For Cervical Cancer: A Review

Cervical cancer is a major global health issue linked to persistent high-risk human papillomavirus infections. Traditional treatments often cause severe side effects, impacting patients' quality of life. This review highlights the potential of nanotechnology, particularly nanoparticles and lipid-based systems, to improve cervical cancer treatment by enabling targeted drug delivery, enhancing treatment effectiveness, and minimizing side effects. Nucleic acid-based therapies, such as siRNAs, show promise due to their specificity but face challenges like degradation. Polymeric and inorganic systems, including PLGA-based nanosystems and mesoporous silica nanoparticles, offer improved drug stability and targeting. Despite advancements, challenges like biocompatibility and large-scale production remain, necessitating further research to maximize nanotechnology's potential in cancer treatment.